CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 163 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,515,000 | -11.3% | 132,571 | +0.6% | 0.15% | -20.7% |
| Q4 2021 | $5,092,000 | +22.0% | 131,771 | +70.5% | 0.18% | +44.9% |
| Q3 2021 | $4,173,000 | +18.8% | 77,285 | -26.4% | 0.13% | +16.5% |
| Q2 2021 | $3,513,000 | +4.2% | 105,056 | -35.8% | 0.11% | +13.5% |
| Q1 2021 | $3,370,000 | +57.6% | 163,615 | +13.5% | 0.10% | -12.7% |
| Q3 2020 | $2,138,000 | -34.2% | 144,200 | -42.3% | 0.11% | -64.9% |
| Q2 2020 | $3,251,000 | – | 250,100 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |